コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 on, coronary angiography, angioplasty and/or coronary artery bypass surgery.
2 heart failure were studied before and after coronary artery bypass surgery.
3 ients who were mechanically ventilated after coronary artery bypass surgery.
4 tery and saphenous vein were obtained during coronary artery bypass surgery.
5 and saphenous vein from patients undergoing coronary artery bypass surgery.
6 nd 54% and 80% in the patients without prior coronary artery bypass surgery.
7 d patients were deemed unsuitable for repeat coronary artery bypass surgery.
8 ytic therapy, and in patients after elective coronary artery bypass surgery.
9 on and 81% and 55% in patients without prior coronary artery bypass surgery.
10 vein were obtained from patients undergoing coronary artery bypass surgery.
11 previous myocardial infarction and previous coronary artery bypass surgery.
12 tery and saphenous vein were obtained during coronary artery bypass surgery.
13 oke, percutaneous coronary intervention, and coronary artery bypass surgery.
14 , and in 51% of patients undergoing a priori coronary artery bypass surgery.
15 r risk of mortality or major morbidity after coronary artery bypass surgery.
16 duction in 10-year all-cause mortality after coronary artery bypass surgery.
17 nical course of patients undergoing elective coronary artery bypass surgery.
18 mg/d) BH4 or placebo for 2 to 6 weeks before coronary artery bypass surgery.
19 cclusion results more than 5 years following coronary artery bypass surgery.
20 inutes of reperfusion in patients undergoing coronary artery bypass surgery.
21 tery bypass surgery with traditional on-pump coronary artery bypass surgery.
22 esearch on the treatment of depression after coronary artery bypass surgery.
23 mental predictor of long-term survival after coronary artery bypass surgery.
24 sures (5 process measures plus survival) for coronary artery bypass surgery.
25 ictor of increased operative mortality after coronary artery bypass surgery.
26 Sixty-five (72%) patients had a previous coronary artery bypass surgery.
27 n of totally endoscopic off-pump multivessel coronary artery bypass surgery.
28 procedures, a totally endoscopic approach to coronary artery bypass surgery.
29 d 45 matched nondiabetic patients undergoing coronary artery bypass surgery.
30 definition of complete revascularization in coronary artery bypass surgery.
31 h ischemic heart disease who were undergoing coronary artery bypass surgery.
33 interventions (17.1% vs 20.0%, P < .001) and coronary artery bypass surgery (2.7% vs 4.2%, P < .01).
34 utaneous coronary intervention (28%), urgent coronary artery bypass surgery (27.5%), maternal mortali
36 nt MI and who had survived and not undergone coronary artery bypass surgery 30 days after discharge w
38 ion, 53 +/- 10%) undergoing cardiac surgery (coronary artery bypass surgery, 88.3%; aortic valve repl
41 versus placebo in patients with a history of coronary artery bypass surgery and found that more aggre
42 rate of inducibility in patients with prior coronary artery bypass surgery and in patients who also
44 ve myocardial infarction, urgent or emergent coronary artery bypass surgery and stroke) and to constr
45 Q-wave myocardial infarction, and emergency coronary artery bypass surgery) and follow-up survival w
46 ngina, percutaneous coronary angioplasty, or coronary artery bypass surgery) and total mortality (CHD
47 the readmitted patients, 13% had PCI, 2% had coronary artery bypass surgery, and 3% died during the r
48 ffered a prior infarction, 20% had undergone coronary artery bypass surgery, and 65% had multivessel
49 se of previously cannulated RAs as grafts in coronary artery bypass surgery, and there are no clear g
52 (MI), coronary intervention (angioplasty, or coronary artery bypass surgery), angina and/or unspecifi
53 eripheral vascular disease, absence of prior coronary artery bypass surgery, angina, low body mass in
55 lacks and 136,362 whites undergoing isolated coronary artery bypass surgery at 663 Society of Thoraci
56 tive patients undergoing first-time isolated coronary artery bypass surgery at our institution from J
58 of Olmsted County, Minnesota, who underwent coronary artery bypass surgery between 1996 and 2007.
59 een associated with lower mortality rates in coronary artery bypass surgery, but how volume and quali
60 ediate and long-term outcomes of reoperative coronary artery bypass surgery (CABG) (n = 1561) and cat
61 441 consecutive patients undergoing elective coronary artery bypass surgery (CABG) after cardiac cath
64 ce with a routine completion angiogram after coronary artery bypass surgery (CABG) and simultaneous (
67 rovide recommendations for optimal timing of coronary artery bypass surgery (CABG) in patients with n
68 is frequently performed in conjunction with coronary artery bypass surgery (CABG) in the United Stat
70 directly compared the incidence of AKI after coronary artery bypass surgery (CABG) or after percutane
73 at pad (FP) can be stimulated at the time of coronary artery bypass surgery (CABG), and if dissection
74 viability tool exclusively in the setting of coronary artery bypass surgery (CABG), and no study has
75 trated increased risk in patients undergoing coronary artery bypass surgery (CABG), but the effect of
76 ith the use of logistic regression modeling, coronary artery bypass surgery (CABG), either isolated o
84 s coronary intervention (PCI) With Taxus and coronary artery bypass surgery (CABG)] score is a decisi
86 myocardial protection in patients undergoing coronary artery bypass surgery contributes to overall ho
87 ificant, the volume-outcome relationship for coronary artery bypass surgery, coronary angioplasty, ca
88 my, lower extremity arterial bypass surgery, coronary artery bypass surgery, coronary angioplasty, he
89 ry of CAD, myocardial infarction, or angina, coronary artery bypass surgery, coronary angioplasty, or
90 rospective study of IMA graft use in initial coronary artery bypass surgery describes substantial var
91 analysis, we excluded patients who underwent coronary artery bypass surgery, died or had acute stent
94 e clinical trial comparing ICR with standard coronary artery bypass surgery for the revascularization
96 high SYNTAX (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr
97 have reported that black patients undergoing coronary artery bypass surgery had worse outcomes than w
99 n internal mammary artery graft (IMA) during coronary artery bypass surgery have increased long-term
100 he following: aortic valve replacement in 9; coronary artery bypass surgery in 3; mitral valve repair
101 g 7944 patients undergoing initial, isolated coronary artery bypass surgery in Maine, New Hampshire,
102 AB surgery is a feasible alternative to open coronary artery bypass surgery in selected patient popul
104 Aspirin usage within the 5 days preceding coronary artery bypass surgery is associated with a lowe
107 t of stenosis in saphenous-vein grafts after coronary-artery bypass surgery is a difficult challenge.
108 patients with multivessel coronary disease, coronary-artery bypass surgery is associated with a bett
110 llation (AF) after minimally invasive direct coronary artery bypass surgery (MIDCAB) and coronary art
111 ry revascularization (HCR) combines arterial coronary artery bypass surgery (most commonly minimally
113 inal arterial bypass, aortobifemoral bypass, coronary artery bypass surgery, oesophagectomy, colectom
114 rhythm was performed in 185 patients during coronary artery bypass surgery of whom 13 had a history
115 te the effectiveness of on-pump and off-pump coronary artery bypass surgery on early clinical outcome
116 s study is to examine the effect of off-pump coronary artery bypass surgery on the risk of postoperat
117 ed trial has assessed the midterm effects of coronary-artery bypass surgery on the beating heart, thi
119 on has been recruited in patients undergoing coronary artery bypass surgery or percutaneous coronary
121 t and coronary artery disease that precluded coronary-artery bypass surgery or percutaneous translumi
123 ope SPECT had not undergone catheterization, coronary artery bypass surgery, or percutaneous translum
124 ng percutaneous coronary intervention (PCI), coronary artery bypass surgery, or valve surgery be refe
126 y intervention in patients with a history of coronary artery bypass surgery (PCI-CABG) is limited and
128 nt risk factor for operative mortality after coronary artery bypass surgery, race does not appear to
130 re efficacious for treating depression after coronary artery bypass surgery, relative to usual care.
131 chocardiography is commonly performed before coronary artery bypass surgery, there has yet to be a st
132 ervational study in 2059 patients undergoing coronary artery bypass surgery to assess the effect of h
133 ular Disease Database (1986-2003) with prior coronary artery bypass surgery undergoing cardiac cathet
134 evaluate operative and extended outcomes of coronary artery bypass surgery using the bilateral inter
137 onary angiograms from 39 patients undergoing coronary artery bypass surgery were evaluated for the ab
138 of procedural mortality and morbidity after coronary artery bypass surgery were higher among black p
140 highlight recent studies comparing off-pump coronary artery bypass surgery with traditional on-pump
142 n (CR) is recommended for all patients after coronary artery bypass surgery, yet little is known abou
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。